Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Prostate Cancer
6 articles
Cabazitaxel: A Promising Second-Line Treatment for Advanced Prostate Cancer
Meta-analysis shows cabazitaxel improves survival in metastatic castration-resistant prostate cancer patients.
PARP Inhibitor Shows Promise in Delaying Prostate Cancer Progression
Study explores rucaparib as ADT-sparing option for nonmetastatic prostate cancer with DNA repair defects
Prostate Cancer Immunotherapy Combo Falls Short in Phase 2 Trial
AZD4635 with durvalumab or oleclumab shows limited efficacy in metastatic castration-resistant prostate cancer
Enzalutamide Improves Outcomes in High-Risk Prostate Cancer
Enzalutamide plus leuprolide or alone significantly delays metastasis in high-risk prostate cancer
Oral Relugolix: A New Horizon in Prostate Cancer Treatment
Study shows oral relugolix has similar quality of life impact to leuprolide for prostate cancer patients
Identifying High-Risk Prostate Cancer Patients for Treatment Escalation
Study finds factors predicting early PSA failure in prostate cancer, suggesting need for more aggressive treatment